Petrelintide Shows Potential for Fewer GI Side Effects than GLP-1 Agonists | Retatrutide News

Petrelintide may cause fewer gastrointestinal side effects than GLP-1 agonists. This could impact future development of GLP-1 drugs like Retatrutide.
Weight Loss · October 24, 2026